Foreign Direct Investment

The latest Drug Administration Law amendments introduce welcome changes such as relaxed permit requirements and free prices. Pharmaceutical companies should keep abreast of the drug pricing reform, and track review and approval changes in the pipeline

China issues a combined negative list for all four FTZs.

Foreign investment catalogue revised to allow more foreign shareholding.

Foreign investment catalogue revised to allow more foreign shareholding.

Enterprises enjoy tax breaks for investment in Western China.

The Measures are revised to follow changes in the List of Investment Projects Subject to Government Check and Approval, which relaxes foreign projects approval requirements.

Foreign banks no longer require a representative office to set up subsidiaries or branches and foreign-invested banks no longer need to allocate minimum capital to set up branches in China

E-commerce WOFEs allowed in Shanghai FTZ.

How MOFCOM deals with existing VIEs and interprets control, and the sectors that will be put on the negative list, will determine the consequences and prospects for both present and future foreign investors